Announcements Trials
Browse Landscape

Phase

Phase 2 50Phase 3 23Phase 1 16Phase 1/2 8Phase 2/3 4Phase NA 3Phase 4 2Phase EARLY_PHASE1 1

Status

Completed 2Withdrawn 1Unknown 1

Sponsor Class

OTHER 2NIH 1INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Colorectal Neoplasms 13Carcinoma, Hepatocellular 6Colonic Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Uterine Cervical Neoplasms 2Rectal Neoplasms 2Ovarian Neoplasms 2Fallopian Tube Neoplasms 2Astrocytoma 2Vipoma 1Squamous Cell Carcinoma of Head and Neck 1Spinal Cord Neoplasms 1Somatostatinoma 1Small Cell Lung Carcinoma 1Recurrence 1Progression Free Survival 1Oropharyngeal Neoplasms 1Oesophagogastric Cancer 1Neuroendocrine Tumors 1Neoplasms 1Neoplasm Metastasis 1Nasopharyngeal Carcinoma 1Mouth Neoplasms 1Mesothelioma 1Lymphoid Interstitial Pneumonia 1Lung Neoplasms 1Laryngeal Neoplasms 1Insulinoma 1Inflammatory Breast Neoplasms 1Hypopharyngeal Neoplasms 1

Interventions

Oxaliplatin 7Fluorouracil 6Leucovorin 5Bevacizumab 4Watchful Waiting 3Capecitabine 3XELOX 2Neoadjuvant Therapy 2Irinotecan 2Indocyanine Green 2Chemotherapy, Adjuvant 2Cetuximab 2sulindac sulfone 1pembrolizumab 1encorafenib 1dehydroftorafur 1cyclopropapyrroloindole 1Tranexamic Acid 1Standard of Care 1Sentinel Lymph Node Biopsy 1Radiofrequency Ablation 1Preoperative Exercise 1Positron Emission Tomography Computed Tomography 1Panitumumab 1Observation 1Mental Status and Dementia Tests 1Magnetic Resonance Spectroscopy 1Iohexol 1In Situ Hybridization, Fluorescence 1Immunohistochemistry 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2/3 × Colonic Neoplasms × Bevacizumab × Clear all
NCT00952029 2020-03-30

Combination Chemotherapy and Bevacizumab With or Without Bevacizumab Maintenance Therapy in Treating Patients With Metastatic Colorectal Cancer

Federation Francophone de Cancerologie Digestive

Phase 2/3 Completed
492 enrolled
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT03686254 2018-09-26

The Effects of RFA in Combination With Second-line Chemotherapy and Bevacizumab on Unresectable CRLM

Nanfang Hospital, Southern Medical University

Phase 2/3 Unknown
160 enrolled
Gastrointestinal

Colonic Neoplasms

NCT00735241 2015-05-22

FAST

Sirtex Medical

Phase 2/3 Withdrawn
Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

NCT00975897 2013-12-19

Study of Tumor Tissue Testing in Selecting Treatment for Patients With Metastatic or Locally Advanced Colorectal Cancer

National Cancer Institute (NCI)

Phase 2/3 Completed
3,240 enrolled
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡